A detailed history of Ellevest, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Ellevest, Inc. holds 18,296 shares of NVS stock, worth $1.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
18,296
Previous 18,202 0.52%
Holding current value
$1.9 Million
Previous $1.94 Million 8.62%
% of portfolio
0.12%
Previous 0.12%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$106.13 - $120.89 $9,976 - $11,363
94 Added 0.52%
18,296 $2.1 Million
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $180,696 - $209,586
1,952 Added 12.01%
18,202 $1.94 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $112,132 - $127,669
1,177 Added 7.81%
16,250 $1.57 Million
Q4 2023

Feb 06, 2024

BUY
$92.27 - $101.54 $41,060 - $45,185
445 Added 3.04%
15,073 $1.52 Million
Q3 2023

Nov 09, 2023

BUY
$94.73 - $105.13 $178,660 - $198,275
1,886 Added 14.8%
14,628 $1.49 Million
Q2 2023

Aug 09, 2023

BUY
$92.52 - $104.91 $121,386 - $137,641
1,312 Added 11.48%
12,742 $1.29 Million
Q1 2023

May 04, 2023

BUY
$80.03 - $92.81 $88,433 - $102,555
1,105 Added 10.7%
11,430 $1.05 Million
Q4 2022

Feb 03, 2023

BUY
$75.55 - $92.52 $329,926 - $404,034
4,367 Added 73.3%
10,325 $936,000
Q3 2022

Nov 02, 2022

SELL
$74.61 - $87.26 $361,560 - $422,861
-4,846 Reduced 44.85%
5,958 $453,000
Q2 2022

Jul 18, 2022

BUY
$80.52 - $93.75 $150,894 - $175,687
1,874 Added 20.99%
10,804 $913,000
Q1 2022

Apr 19, 2022

BUY
$80.11 - $90.62 $128,977 - $145,898
1,610 Added 21.99%
8,930 $784,000
Q4 2021

Jan 24, 2022

SELL
$79.7 - $88.13 $19,128 - $21,151
-240 Reduced 3.17%
7,320 $640,000
Q3 2021

Oct 19, 2021

BUY
$81.78 - $95.14 $137,390 - $159,835
1,680 Added 28.57%
7,560 $618,000
Q2 2021

Jul 13, 2021

BUY
$85.24 - $94.15 $73,391 - $81,063
861 Added 17.15%
5,880 $536,000
Q1 2021

May 03, 2021

BUY
$83.5 - $98.47 $74,899 - $88,327
897 Added 21.76%
5,019 $429,000
Q4 2020

Feb 04, 2021

BUY
$78.07 - $94.43 $95,089 - $115,015
1,218 Added 41.94%
4,122 $389,000
Q3 2020

Oct 26, 2020

BUY
$82.14 - $91.0 $3,203 - $3,549
39 Added 1.36%
2,904 $253,000
Q2 2020

Jul 06, 2020

BUY
$80.93 - $91.1 $94,526 - $106,404
1,168 Added 68.83%
2,865 $250,000
Q1 2020

Apr 13, 2020

BUY
$70.67 - $99.01 $69,397 - $97,227
982 Added 137.34%
1,697 $140,000
Q4 2019

Feb 05, 2020

BUY
$84.35 - $95.37 $59,044 - $66,759
700 Added 4666.67%
715 $68,000
Q3 2019

Oct 08, 2019

SELL
$85.54 - $94.26 $9,666 - $10,651
-113 Reduced 88.28%
15 $1,000
Q2 2019

Aug 20, 2019

BUY
$75.4 - $92.8 $9,651 - $11,878
128 New
128 $12,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.